JNJ vs AMGN
By Alex · Tickerpine
Johnson & Johnson vs Amgen Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | AMGN |
|---|---|---|
| Price | $285.75 | $465.67 |
| Market cap | $687.89B | $251.89B |
| P/E ratio | 43.4 | 27.0 |
| ROE | 20.02% | 78.35% |
| Profit margin | 16.20% | 24.14% |
| Revenue growth | 5.90% | 8.50% |
| Dividend yield | 1.88% | 2.16% |
| Beta | 0.20 | 0.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs AMGN in plain English
- JNJ is the bigger company — about 2.7× the market cap of AMGN.
- AMGN is cheaper on earnings (P/E 27.0 vs 43.4).
- AMGN earns a higher return on equity (78% vs 20%).
- AMGN is growing revenue faster (8% vs 6%).
- AMGN has the higher dividend yield (2.16% vs 1.88%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.